Bipolar disorder (BD) has recently become a very popular topic. There are over 100 books about BD reachable on the market, from howto-books and self-help manuals to first-person accounts. Unlike other manuals focused mostly on medications, this book stands out as a fairly unique one as it attempts to help clinician needs and addresses important treatment issues. Rather than surveying, as usual, the available medications and the literature about their clinical trials, this book provides the needed advice on how to proceed and make treatment decisions in different stages of the illness. The focus is on useful strategies in clinical practice. The literature is critically evaluated and summarized, along with the authors' substantial experience from their own clinical involvement.
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Both authors have been active in practice and research on mood disorders at the University of California, Los Angeles, Michael J Gitlin as a psychiatrist and David J Miklowitz as a psychologist and psychotherapist. They point out that these days many people with BD receive chaotic, ineffective care; a problem they attempt to avoid with their rational, practical approach.
Starting with the basics of BD, they proceed to cover the main controversies currently being debated among clinicians and researchers. They stress the importance of systematic intake evaluation, of pharmacological approaches while treating acute mania and acute depression and of combining pharmacological and psychosocial approach during the maintenance phase. They deal with nonadherent patients, suicide prevention, BD comorbidity, and with unique issues faced by women during pregnancy and postpartum. As key themes of the book, the authors underline that the treatment of BD must be individualized in an ongoing collaboration with each patient; that it is necessary to continually re-evaluate a patient's clinical presentation and situation, and to adjust treatment plans accordingly. Family members are integral members of the treatment plans. While a good intake evaluation is crucial, it is also important to continue collecting illness data on a continuous basis.
The book is a lucidly written, amazingly erudite, highly readable account of often complex clinical matters and the most challenging, common clinical problem is, however, the choice of effective treatment of bipolar depression and long-term stabilization. I feel that here, their sensible recommendations do not go far enough; one can address both the heterogeneity of presentations and individualized treatments through BD subtypes. The authors do stress that the treatment of bipolar depression is a clinical conundrum and that there is an astounding paucity of useful studies to help us in dealing with it. Therefore, they provide only general treatment principles and strategies to use with different medications and, naturally, as Americans they stress the options approved by the Food and Drug Administration.
In addition to BD diagnosis and symptoms, systematic evaluation of an individual patient offers rich information about the patient's clinical course, family history, comorbidity, and other aspects of the clinical profile. While the authors correctly state that there is not sufficient agreement in the literature about subtypes of BD illness, during the past 35 years a number of authors, for example Angst, 1 Alda, 2 and Masi, 3 have reported major clinical subtypes with similar clinical profiles. That is where the treatment based on the individual information from each patient actually pays good dividends. Focusing on these subtypes can markedly improve treatment outcome in maintenance and in the treatment of acute depression. Such an approach can reduce the rationale-lacking polypharmacy that so often takes place, and the frequently chaotic, ineffective treatment that the authors correctly criticize.
